AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BIOXYNE LTD

0.046

+0.0012.22%

Volume:2.77M

Turnover:125.64K

Market Cap:103.04M

PE:20.00

High:0.046

Open:0.045

Low:0.045

Close:0.045

52wk High:0.060

52wk Low:0.019

Shares:2.24B

Float Shares:595.07M

Volume Ratio:1.40

T/O Rate:0.47%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.002

EPS(LYR):0.002

ROE:63.65%

ROA:24.26%

PB:8.30

PE(LYR):20.00

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies+0.93%

Capital Flow

Inflow:

Outflow:

News

Why Investors Shouldn't Be Surprised By Bioxyne Limited's (ASX:BXN) 30% Share Price Surge

Simply Wall St.

Bioxyne Secures Initial Purchase Orders for Psychedelic Drug; Shares Rise 7%

MT Newswires Live

BRIEF-Bioxyne Commercialises GMP-Manufactured Psilocybin Capsules

Bioxyne Ltd - Commercialises Gmp-Manufactured Psilocybin Capsules

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BXN.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BXN.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BXN.AU\",,,,,undefined,":{"symbol":"BXN.AU","market":"AU","secType":"STK","nameCN":"BIOXYNE LTD","latestPrice":0.046,"timestamp":1771477920000,"preClose":0.045,"halted":0,"volume":2767615,"delay":0,"changeRate":0.022222222222222244,"nameEN":"BIOXYNE LTD","floatShares":595070503,"shares":2239909288,"eps":0.0023,"marketStatus":"Not Yet Opened","change":0.001,"latestTime":"02-19 16:12:00 AEDT","open":0.045,"high":0.046,"low":0.045,"amount":125635,"amplitude":0.022222,"askPrice":0.046,"askSize":253715,"bidPrice":0.045,"bidSize":336196,"shortable":3,"etf":0,"ttmEps":0.0023,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1771542000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.045,"openAndCloseTimeList":[[1771455600000,1771477200000]],"volumeRatio":1.395377,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BXN.AU\",,,,,undefined,":{"symbol":"BXN.AU","floatShares":595070503,"roa":"24.26%","roe":"63.65%","lyrEps":0.0023,"volumeRatio":1.395377,"shares":2239909288,"dividePrice":0,"high":0.046,"amplitude":0.022222,"preClose":0.045,"low":0.045,"week52Low":0.019,"pbRate":"8.30","psRate":"3.52","week52High":0.06,"institutionHeld":0,"latestPrice":0.046,"committee":0.139819,"eps":0.0023,"divideRate":0,"volume":2767615,"delay":0,"ttmEps":0.0023,"open":0.045,"prevYearClose":0.042,"prevWeekClose":0.048,"prevMonthClose":0.039,"prevQuarterClose":0.042,"fiveDayClose":0.046,"twentyDayClose":0.038,"sixtyDayClose":0.038,"earningDate":1771948800000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BXN.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-25","symbol":"BXN.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771974000000,"name":null,"time":"","dateTimestamp":1771938000000,"actualEps":null},{"date":"2025-07-28","symbol":"BXN.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1753660800000,"name":null,"time":"","dateTimestamp":1753624800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BXN.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BXN.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611319193","title":"Why Investors Shouldn't Be Surprised By Bioxyne Limited's (ASX:BXN) 30% Share Price Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2611319193","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611319193?lang=en_us&edition=fundamental","pubTime":"2026-02-14 04:58","pubTimestamp":1771016315,"startTime":"0","endTime":"0","summary":"Bioxyne Limited ( ASX:BXN ) shares have had a really impressive month, gaining 30% after a shaky period beforehand...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/household/asx-bxn/bioxyne-shares/news/why-investors-shouldnt-be-surprised-by-bioxyne-limiteds-asxb","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/household/asx-bxn/bioxyne-shares/news/why-investors-shouldnt-be-surprised-by-bioxyne-limiteds-asxb","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7111","BXN.AU","BK4211","BK7508","ISBC"],"gpt_icon":0},{"id":"2610606323","title":"Bioxyne Secures Initial Purchase Orders for Psychedelic Drug; Shares Rise 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610606323","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610606323?lang=en_us&edition=fundamental","pubTime":"2026-02-11 10:00","pubTimestamp":1770775250,"startTime":"0","endTime":"0","summary":"Bioxyne  secured initial purchase orders for the supply of psilocybin capsules, or BLSPSIL25, through its wholly-owned unit Breathe Life Sciences, according to a Wednesday Australian bourse filing.The capsules are intended for investigational use in treatment-resistant depression and exploratory research into other mental health conditions in Australia, including anxiety disorders, substance use disorders, and post-traumatic stress disorder.These initial orders involve the supply of 250 doses of BLSPSIL25 to authorized prescribers in Queensland and Western Australia, supporting treatment for around 60 patients over the next 12 months.Bioxyne's shares rose nearly 7% in recent trading on Wednesday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","XKO.AU","BXN.AU","BK7111","XJO.AU","XAO.AU"],"gpt_icon":0},{"id":"2610605317","title":"BRIEF-Bioxyne Commercialises GMP-Manufactured Psilocybin Capsules","url":"https://stock-news.laohu8.com/highlight/detail?id=2610605317","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610605317?lang=en_us&edition=fundamental","pubTime":"2026-02-11 09:38","pubTimestamp":1770773911,"startTime":"0","endTime":"0","summary":"BRIEF-Bioxyne Commercialises GMP-Manufactured Psilocybin CapsulesFeb 11 (Reuters) - Bioxyne Ltd BXN.AX:COMMERCIALISES GMP-MANUFACTURED PSILOCYBIN CAPSULESFurther company coverage: BXN.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nFWN3Z61EQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BXN.AU","BK7508","BK7111"],"gpt_icon":0},{"id":"2610679384","title":"Bioxyne Ltd - Commercialises Gmp-Manufactured Psilocybin Capsules","url":"https://stock-news.laohu8.com/highlight/detail?id=2610679384","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610679384?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:18","pubTimestamp":1770758331,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z61EQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BXN.AU","BK7111","BK7508"],"gpt_icon":0}],"pageSize":4,"totalPage":10,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BXN.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":0.009301}]}}